Differences in gut microbiota and its metabolic function among different fasting plasma glucose groups in Mongolian population of ChinaOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined how gut bacteria and their metabolic functions differ across fasting glucose groups in a Mongolian population. It also tested links between diet and specific bacteria. Researchers used shotgun metagenomic sequencing of fecal DNA to measure microbial composition, gene content, and KEGG-annotated metabolic pathways. Dietary intake was captured with a 69-item food frequency questionnaire, and correlations with bacteria and enzymes were assessed statistically.
Who was studied?
The cohort was 24 pure-lineage Mongolian volunteers in Inner Mongolia, China, screened from 160 candidates. All were newly diagnosed and unmedicated. Participants were grouped by fasting plasma glucose into type 2 diabetes (6 cases), prediabetes (6 cases), and normal glucose controls (12 cases). Groups were matched for sex and similar age. They differed significantly in fasting glucose, waistline, and waist-to-hip ratio but not in BMI or blood pressure.
What were the most important findings?
The Clostridium genus was the top discriminating bacterium, with the highest LDA score in the diabetes group and no genus exceeding the threshold in the other groups. Clostridium abundance dipped in prediabetes then rose highest in type 2 diabetes. Metabolic enzyme genes were more abundant in prediabetes and diabetes than in controls. Daily carotene intake correlated negatively with Clostridium abundance (Spearman -0.423). Carotene and seafood intake also correlated negatively with fasting glucose.
What are the greatest implications of this study?
The results propose the gut Clostridium genus as a candidate biomarker for type 2 diabetes in Mongolian people, testable by simple qPCR. Shifts in carbohydrate, amino acid, lipid, and energy metabolism appeared early, in the prediabetes stage, suggesting microbial function changes before overt disease. The sample size was small and diet relied on recall, so the authors call for validation in larger populations before clinical use.